Nothing but bloody glossy presentations and lack of execution year over year. Another share raise and dilution just around the corner and a hole almost too deep to dig out of based on what ole Judith did to this company with such a horrid go to market strategy early on. Bloody IV is in the eye of the storm and already on borrowed time. I think they’re better off to sell the patents and let one of the big wound care companies take it from here. Cheers.
Nothing but bloody glossy presentations and lack of execution...
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
0.025(10.0%) |
Mkt cap ! $80.21M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 27.5¢ | 25.0¢ | $33.39K | 125.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 17850 | 2 |
View Market Depth
| Last trade - 15.53pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
27.0¢ |
Change
0.025 ( 3.85 %) |
||||
| Open | High | Low | Volume | ||
| 25.5¢ | 27.0¢ | 25.5¢ | 35996 | ||
| Last updated 15.53pm 17/06/2024 ? | |||||
| NXS (ASX) Chart |
